CAPTRUST Financial Advisors’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.4K | Buy |
17,039
+637
| +4% | +$911 | ﹤0.01% | 2466 |
|
|
2025
Q1 | $26.2K | Buy |
16,402
+2,073
| +14% | +$3.32K | ﹤0.01% | 2310 |
|
|
2024
Q4 | $51.6K | Sell |
14,329
-678
| -5% | -$2.44K | ﹤0.01% | 2235 |
|
|
2024
Q3 | $85.5K | Buy |
15,007
+185
| +1% | +$1.06K | ﹤0.01% | 2207 |
|
|
2024
Q2 | $68.5K | Hold |
14,822
| – | – | ﹤0.01% | 2133 |
|
|
2024
Q1 | $121K | Hold |
14,822
| – | – | ﹤0.01% | 2047 |
|
|
2023
Q4 | $83.7K | Sell |
14,822
-33
| -0.2% | -$186 | ﹤0.01% | 2545 |
|
|
2023
Q3 | $27.6K | Sell |
14,855
-1,875
| -11% | -$3.49K | ﹤0.01% | 2511 |
|
|
2023
Q2 | $46K | Buy |
16,730
+1,388
| +9% | +$3.82K | ﹤0.01% | 2434 |
|
|
2023
Q1 | $48.2K | Buy |
+15,342
| New | +$48.2K | ﹤0.01% | 2216 |
|
|
2022
Q4 | – | Sell |
-14,822
| Closed | -$130K | – | 2079 |
|
|
2022
Q3 | $130K | Hold |
14,822
| – | – | ﹤0.01% | 1901 |
|
|
2022
Q2 | $112K | Hold |
14,822
| – | – | ﹤0.01% | 2120 |
|
|
2022
Q1 | $360K | Sell |
14,822
-4,940
| -25% | -$120K | ﹤0.01% | 1330 |
|
|
2021
Q4 | $636K | Sell |
19,762
-6,587
| -25% | -$212K | ﹤0.01% | 1004 |
|
|
2021
Q3 | $1.18M | Hold |
26,349
| – | – | 0.01% | 690 |
|
|
2021
Q2 | $997K | Buy |
26,349
+26,241
| +24,297% | +$993K | 0.01% | 720 |
|
|
2021
Q1 | $4K | Buy |
+108
| New | +$4K | ﹤0.01% | 3797 |
|